Abacus Life Statistics
Total Valuation
Abacus Life has a market cap or net worth of $760.88 million. The enterprise value is $880.16 million.
| Market Cap | 760.88M |
| Enterprise Value | 880.16M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Abacus Life has 75.48 million shares outstanding. The number of shares has increased by 25.13% in one year.
| Shares Outstanding | 75.48M |
| Shares Change (YoY) | +25.13% |
| Shares Change (QoQ) | -6.17% |
| Owned by Insiders (%) | 81.96% |
| Owned by Institutions (%) | 0.48% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 16.77 |
| PS Ratio | 9.79 |
| Forward PS | 6.37 |
| PB Ratio | 4.61 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 10,684.46 |
| EV / Sales | 11.33 |
| EV / EBITDA | 40.51 |
| EV / EBIT | 53.15 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.12, with a Debt / Equity ratio of 1.14.
| Current Ratio | 3.12 |
| Quick Ratio | 3.03 |
| Debt / Equity | 1.14 |
| Debt / EBITDA | 8.66 |
| Debt / FCF | n/a |
| Interest Coverage | 1.26 |
Financial Efficiency
Return on equity (ROE) is 0.10% and return on invested capital (ROIC) is 0.14%.
| Return on Equity (ROE) | 0.10% |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 0.14% |
| Revenue Per Employee | $761,592 |
| Profits Per Employee | $808 |
| Employee Count | 102 |
| Asset Turnover | 0.24 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Abacus Life has paid $3.30 million in taxes.
| Income Tax | 3.30M |
| Effective Tax Rate | 97.56% |
Stock Price Statistics
The stock price has increased by +61.80% in the last 52 weeks. The beta is 0.17, so Abacus Life's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | +61.80% |
| 50-Day Moving Average | 10.15 |
| 200-Day Moving Average | 9.93 |
| Relative Strength Index (RSI) | 58.70 |
| Average Volume (20 Days) | 167,949 |
Short Selling Information
The latest short interest is 172,552, so 0.23% of the outstanding shares have been sold short.
| Short Interest | 172,552 |
| Short Previous Month | 372,407 |
| Short % of Shares Out | 0.23% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 15.66 |
Income Statement
In the last 12 months, Abacus Life had revenue of $77.68 million and earned $82,378 in profits.
| Revenue | 77.68M |
| Gross Profit | 68.96M |
| Operating Income | 20.62M |
| Pretax Income | 3.38M |
| Net Income | 82,378 |
| EBITDA | 21.73M |
| EBIT | 16.56M |
| Earnings Per Share (EPS) | -$0.01 |
Balance Sheet
The company has $68.79 million in cash and $188.07 million in debt, giving a net cash position of -$119.28 million or -$1.58 per share.
| Cash & Cash Equivalents | 68.79M |
| Total Debt | 188.07M |
| Net Cash | -119.28M |
| Net Cash Per Share | -$1.58 |
| Equity (Book Value) | 165.13M |
| Book Value Per Share | 2.19 |
| Working Capital | 50.49M |
Cash Flow
In the last 12 months, operating cash flow was -$44.88 million and capital expenditures -$351,461, giving a free cash flow of -$45.23 million.
| Operating Cash Flow | -44.88M |
| Capital Expenditures | -351,461 |
| Free Cash Flow | -45.23M |
| FCF Per Share | -$0.72 |
Margins
Gross margin is 88.77%, with operating and profit margins of 26.55% and 0.11%.
| Gross Margin | 88.77% |
| Operating Margin | 26.55% |
| Pretax Margin | 4.35% |
| Profit Margin | 0.11% |
| EBITDA Margin | 27.97% |
| EBIT Margin | 21.32% |
| FCF Margin | -58.22% |
Dividends & Yields
Abacus Life does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.13% |
| Shareholder Yield | -25.13% |
| Earnings Yield | 0.01% |
| FCF Yield | -5.94% |
Analyst Forecast
The average price target for Abacus Life is $13.50, which is 33.93% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.50 |
| Price Target Difference | 33.93% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Abacus Life has an Altman Z-Score of 2.54 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.54 |
| Piotroski F-Score | 2 |